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ABSTRACT  
Background: One of the causes of chronic diarrhea is pancreatic exocrine insufficiency. Chronic 
diarrhea cases are commonly encountered in Indonesia.  
Materials & Methods: All patients with chronic diarrhea at hospitals in Jakarta were included in this study and 
dyspeptic patients were used as control subjects. The study and control subjects must submit their stool for fecal 
pancreatic elastase-1 examination at a private laboratory in Jakarta. Mild/moderate pancreatic exocrine 
insufficiency was defined if the concentration was between 100 - 200 µg E1/g stool. Severe pancreatic 
exocrine insufficiency was defined if the concentration was below 100 µg E1/g stool. The data was analyzed using 
Fisher or Kruskal-Wallis tests.  
Results: There were 32 chronic diarrhea patients with a male to female ratio of 19/13 (59.38%/40.62%).  
The most frequent age range was 50-59 years old (39.5%). The characteristics (sex, age and race) of chronic  
diarrhea patients were matched with the characteristics of dyspeptic patients as control subjects (p > 0.05).  
The fecal elastase-1 results in chronic diarrhea displayed greater pancreatic exocrine insufficiency  
(< 200 µg E1/g stool) than in dyspepsia (control) (> 200 µg E1/g stool, p < 0.001). The mean fecal elastase-1  
result in chronic diarrhea and in dyspepsia were 316.29 + 195.44 vs. 475.93 + 65.33 µg E1/g stool  
(p < 0.001). Six patients (18.74%) were established as having severe pancreatic exocrine insufficiency. Seven 
patients (21.88%) were found with mild/moderate pancreatic exocrine insufficiency.  
 Conclusion: Pancreatic exocrine insufficiency was found   frequently in chronic diarrhea.  
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INTRODUCTION 
Chronic diarrhea cases are commonly encountered in  
Indonesia.1 One of the causes of chronic diarrhea is  
pancreatic  exocrine  insufficiency.  Pancreatic  
insufficiency occurs if the pancreas is unable to secrete  
chemicals and digestive enzymes for normal digestion.  
If the pancreatic insufficiency is severe, malabsorption  
occurs, causing reduced absorption of essential nutrients  
and the development of watery stool containing  
unabsorbed fat (steatorrhea). Mild pancreatic insufficiency  
is often difficult to diagnose. There are two kinds of  
pancreatic exocrine insufficiency, which are primary and  
secondary pancreatic exocrine insufficiency. Primary  
pancreatic insufficiency is caused by pancreatic  
abnormalities, such as cystic fibrosis, chronic  
pancreatitis, pancreatic resection surgery, pancreatic  
tumor, and diabetes mellitus. Secondary pancreatic 
insufficiency is caused by bowel disease, such as celiac 
disease, tropical sprue, Crohn’s disease, and autoimmune  
diseases such as systemic lupus erythematosus.2-5  
 One of the efforts to detect pancreatic exocrine  
insufficiency is the fecal pancreatic elastase-1 test.6-13  
This examination is one of the pancreatic function tests  
that does not use a tube and does not require a lot of  
time.6 SZIEGOLEIT14,15 is the founder of human  
pancreatic elastase-1, which is classified as an acid  
elastase, as an endoprotease and new sterol-binding  
protein that is found in human pancreatic secretion and  
stool. Human pancreatic elastase-1 does not degraded  
during bowel transit. Fecal elastase-1 levels are 5 to 6  
times that of pancreatic fluid, and fecal elastase remains  
stable for 1 week in room temperature. Thus, fecal  
elastase-1 concentrations reflect pancreatic exocrine  
function.15,16 The sensitivity of pancreatic elastase-1 test  
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in mild pancreatic insufficiency ranges around 0 to 63%, 
77 - 100% in moderate pancreatic insufficiency, and 100% 
in severe pancreatic insufficiency.7,17,18,19 The specificity 
of elastase-1 in stool is 93%. 
Other direct pancreatic exocrine examination such as  
the secretin-cholecystokinine test or caerulein secretin,  
even though considered gold standards, are not available  
in Indonesia, are not practical, time-consuming, invasive,  
and expensive.12 Other indirect tests such as the dilaurate  
fluorescence test, NBT-PABA, or bentiromide, fecal  
chymotrypsin, have only limited sensitivity for mild/  
moderate pancreatic insufficiency, and are influenced by  
several drugs, diarrhea, pH, as well as gastrointestinal  
surgery, thereby reducing their specificity.12 Based on  
the above, this study uses the fecal pancreatic elastase-1  
test to assess pancreatic exocrine function. 
 
MATERIALS AND METHODS 
All patients with chronic diarrhea at our hospital and  
other private hospitals in Jakarta and dyspeptic patients  
were used as control subjects were included in this study.  
Chronic diarrhea was diagnosed if the passage of stool  
were more than 200 g per day or if passage of soft and  
watery stool was more than 3 times per day with or  
without blood or mucous in the stool and it lasted more  
than 15 days. The study and control subjects must submit  
a stool sample for fecal pancreatic elastase-1  
examination at a private laboratory in Jakarta. Fecal  
pancreatic elastase-1 concentration was measured using  
ELISA (ScheboR, Tech, Germany). All patients with  
chronic   diarrhea underwent history taking, physical  
examination, ultrasound examination, esophagogastro- 
duodenoscopy, colonoscopy, and laboratory examinations  
including stool sample, routine blood examination, blood  
sugar, liver function, thyroid function, serum amylase- 
lipase, etc. All patients with dyspepsia underwent  history  
taking, physical examination, ultrasound examination,  
upper abdominal CT-scan (if necessary), esophago- 
gastroduodenoscopy, colonoscopy, and laboratory  
evaluation. 
The exclusion criteria were lack of cooperation, heart  
failure, severe pulmonary obstruction, renal failure, and  
peptic ulcer in the group with dyspepsia. Mild/moderate  
pancreatic exocrine insufficiency was defined if  
the concentration was between 100-200 µg E1/g stool.  
Severe pancreatic exocrine insufficiency was defined if  
the concentration was below 100 µg E1/g stool. Normal  
pancreatic  exocrine  function  was  defined  if  
the concentration was the same or above 200 µg E1/g  
stool.12  The data was analyzed using Fisher or Kruskal- 
Wallis tests. 
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RESULTS 
There were 32 chronic diarrhea patients with a male  
to female ratio of 19/13 (59.38%/40.62%) and 32  
dyspeptic patients as control subjects. The most frequent  
age  range  was  50-59  years  old  (37.5%). 
The characteristics (sex, age and race) of chronic  
diarrhea patients were matched with the characteristics  
of dyspeptic patients as control subjects (p > 0.05).  
The fecal pancreatic elastase-1 results in chronic  
diarrhea displayed greater pancreatic exocrine  
insufficiency (< 200 µg E1/g stool) than in dyspepsia as  
control subject (> 200 µg E1/g stool). The difference in  
fecal pancreatic elastase-1 results was significant  
(p < 0.001). The mean fecal pancreatic elastase-1 result  
in chronic diarrhea and in dyspepsia were 316.29 + 195.44  
vs. 475.93 + 65.33 µg E1/g stool (p < 0.001). Thirteen  
(40.62%) patients had pancreatic exocrine insufficiency.  
Six patients (18.74%) were categorized as having severe  
pancreatic exocrine insufficiency. Seven patients (21.88%)  
were found with mild/moderate pancreatic exocrine  
insufficiency. 
5  
Table 1. Characteristics of Patients with Chronic 
Diarrhea and Dyspeptic Syndrome 
Characteristic 
Chronic 
Diarrhea 
(n=32) 
Dyspeptic 
Syndrome  
(n=32) 
p 
Age (years old) 
10 - 19 
20 - 29 
30 - 39 
40 - 49 
50 - 59 
60 - 69 
70 - 79 
80 - 89 
 
0 
1 
4 
6 
12 
6 
3 
0 
 
3 
1 
11 
4 
7 
5 
0 
1 
 
0.09 
Sex 
Male 
Female 
 
19 
13 
 
20 
12 
 
0.79 
Ethnic group 
Javanese 
Chinese 
Sundanese 
Padangnese 
Bataknese 
Other 
 
3 
16 
2 
2 
1 
2 
 
7 
21 
0 
1 
1 
2 
 
0.57 
Results of fecal 
elastase-1  
(g E1/g stool) 
< 200 
> 200 
 
 
 
13 
19 
 
 
 
0 
32 
 
 
 
< 0.001 
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Table 2. The Correlation between Results of Fecal Pancreatic Elastase-1 and Patient 
Characteristics 
Characteristic 
Mean Fecal Pancreatic Elastase-1 Level 
g E1/g stool) 
p 
Type of disease 
 Chronic diarrhea 
 Dyspeptic syndrome 
 
 316.29 + 195.44 
475.93  +  65.33 
 
< 0.001 
Sex   
Male 
Female 
 
386.73 + 166.01 
410.74 + 166.85 
 
0.58 
Age (years old) 
10 - 19 
20 - 29 
30 - 39 
40 - 49 
50 - 59 
60 - 69 
70 - 79 
80 - 89 
 
400.57 + 172.22 
500.00 +     0.00 
467.08 + 100.58 
379.52 + 195.89 
370.74 + 178.55 
342.02 + 173.63 
347.17 + 264.72 
500.00 +     0.00 
 
0.53 
 
Table 3. Illness Found in Chronic Diarrhea 
Illness in Chronic Diarrhea Frequency (n=32) 
Percentage 
(%) 
Gluten enteropathy 
HIV 
Irritable Bowel Syndrome 
Infective colitis 
Colonic cancer 
Liver cirrhosis/chronic hepatitis 
Diabetes mellitus 
Ulcerative colitis 
Thyrotoxicosis 
Chronic pancreatitis 
Pancreatic cancer 
Unknown 
3 
1 
3 
13 
1 
2 
3 
1 
1 
1 
1 
2 
9.37 
3.13 
9.37 
40.63 
3.13 
6.24 
9.37 
3.13 
3.13 
3.13 
3.13 
6.24 
Note: There could be one or more abnormalities in one case 
Table 4. Pancreatic Exocrine Insufficiency among Patients with Chronic Diarrhea 
Illness in 
Chronic Diarrhea 
Mild/moderate Pancreatic 
Insufficiency or  
Fecal Pancreatic Elastase-1  
100-200 µg E1/g stool (n=7) 
Severe Pancreatic 
Insufficiency or  
Fecal Pancreatic Elastase-1  
< 100 µg E1/g stool (n=6) 
Chronic pancreatitis 0 1 
Pancreatic cancer 0 1 
Diabetes mellitus 1 0 
Gluten enteropathy 1 0 
Thyrotoxicosis + infective colitis 1 0 
HIV + infective colitis 1 0 
Infective colitis 1 1 
Colonic cancer 0 1 
Irritable bowel syndrome 2 0 
Unknown 0 2 
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Two out of 3 patients (66.67%) with pancreatic 
abnormality had severe pancreatic exocrine insufficiency 
(fecal  pancreatic  elastase-1  of  less  than  
100 µg E1/g stool). There were 1 out of 3 (33.33%) cases of 
mild/moderate pancreatic exocrine insufficiency among 
patients with pancreatic abnormality. Two out of 8 
patients (25%) with bowel (extra-pancreatic) 
abnormality had severe pancreatic exocrine insufficiency,  
while 6 out of 8 cases (75%) with bowel (extra- 
pancreatic) abnormality had mild/moderate pancreatic  
exocrine insufficiency. There were 2 cases with severe  
pancreatic exocrine insufficiency whose the cause of  
chronic diarrhea was unknown, but this is most probably  
caused by pancreatic abnormality, as bowel and gastric  
examinations exhibited normal findings (see table 4). 
 
DISCUSSION 
In the group of chronic diarrhea, there was a fecal  
pancreatic elastase-1 result of < 200 µgE1/g stool, which  
is greater than among dyspeptic patients (13 cases  
compared to 0). This is in line with references that state  
that pancreatic exocrine insufficiency can be caused by  
pancreatic disease or intestinal disease and not due to  
gastric or esophageal abnormality. Chronic diarrhea can  
of course be caused by pancreatic or intestinal disease or  
abnormality.2-5 The characteristics of the chronic  
diarrhea group and that with dyspepsia have been  
arranged from the inclusion to be the same and not  
significantly different, in order to reduce bias in  
the examination of fecal pancreatic elastase-1.  
 From this study, we found that in patients with chronic  
diarrhea due to pancreatic abnormality, the degree of  
pancreatic insufficiency is more severe compared to in  
patients with chronic diarrhea due to bowel abnormality  
(66.67% vs. 25%). Among patients with pancreatic  
abnormality, more had fecal pancreatic elastase-1 levels  
of less than 100 µgE1/g stool. This is in line with  
references that state that the concentration of fecal  
elastase among patients with chronic pancreatitis is  
significantly lower than among patients with  
non-pancreatic gastrointestinal disease.12, 19 In this study,  
in cases with chronic pancreatitis and pancreatic  
cancer, more severe pancreatic exocrine insufficiency was  
found.  During  severe  pancreatic  exocrine  
insufficiency, there are usually symptoms of  
malabsorption and chronic fatty diarrhea (steatorrhea).  
 The mean of fecal pancreatic elastase-1 result in  
patients with chronic diarrhea is significantly lower  
compared to patients with dyspepsia (316.29 +  
196.44  µg E1/g stool vs. 475.93 + 65.33  µg E1/g stool).  
This finding is in line with other findings that found that  
the chronic pancreatitis is significantly lower than that of 
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normal subjects or patients with non-pancreatic intestinal 
disease.12,19 
It is evident that fecal pancreatic elastase-1 is not  
related to sex and age. This finding is in line with other 
references.7,9,10,20 
Chronic diarrhea may be caused by abnormalities or  
other diseases like gluten enteropathy, infective colitis,  
chronic pancreatitis, etc., but these abnormalities/ diseases  
may not be the sole cause of chronic diarrhea. In one  
case of chronic diarrhea there could be more than one  
cause. This result is in line with previous studies.1  
According to a reference, diabetes mellitus could be  
accompanied by pancreatic insufficiency,8 but in this study  
only one diabetic had pancreatic exocrine insufficiency.  
 Among patients with intestinal disease, there is a  
possibility  to  have   secondary   pancreatic 
insufficiency.12,19,21 This is in line with the findings from 
this study, where secondary pancreatic insufficiency is 
found in patients with colonic cancer and infective 
colitis. The correlation between intestinal abnormality and 
pancreatic exocrine dysfunction is unclear.21 
In this study, there was a problem in diagnosing  
primary pancreatic abnormality such as cystic fibrosis,  
etc, due to the lack of laboratory facilities in Indonesia  
and limitations in the cost of this study. In this study, there  
were 2 (two) cases where no clear cause of chronic  
diarrhea was found, but they have severe pancreatic  
insufficiency (< 100 µgE1/g stool). This abnormality  
indicates pancreatic disease, even though this was not  
proven or detected using the available diagnostic  
facilities. Thus, fecal pancreatic elastase-1 examination  
can assist physicians in detecting and treating the cause 
of chronic diarrhea.20, 21, 22 
CONCLUSION 
Pancreatic exocrine insufficiency was found 
frequently in chronic diarrhea. 
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